May 1, 2017 (Newswire.com) –
ivWatch, LLC, is pleased to announce that their Model 400, a peripheral IV monitoring device, is a finalist in the 19th Annual Medical Device Excellence Awards competition sponsored by MD&M East, the largest annual medical technology conference on the East Coast. Winners will be announced during the June conference in New York.
“It’s an honor to be named as one of the finalists. Having our device recognized by the MDEA judges validates our commitment to helping reduce patient harm and improving patient safety outcomes.”
The ivWatch Model 400 is a device that continuously monitors a patient’s peripheral IV for the early detection of infiltrations – when medication or fluid leaks outside the vein into the surrounding tissue. Intravenous therapy is a routine part of treatment for nearly 80% of patients in the U.S., and more than 20% of these IVs may fail because of infiltration. Because every IV failure risks both a serious drug delivery error and tissue damage, earlier detection of those failures is the new and next step for minimizing this potential for patient harm.
The team at ivWatch are recognized leaders in the field of tissue optics, biomedical engineering, computational optical modeling and sensor design. The technological advance represented by this device addresses the challenge of delivering high performance sensitivity and accuracy of reporting, and aligns with the medical industry’s dedication to patient safety and quality of care.
Thanks to close collaboration with nurses and doctors, the Model 400 fits easily into existing workflows. Leading hospitals across the U.S. who have been using the Model 400 are realizing the benefits of this new technology, improving both the effectiveness of drug delivery and the safety of their patients.
The MDEA competition recognizes significant achievements in medical product design and engineering that improve healthcare delivery and accessibility. The awards celebrate the accomplishments of the medical device manufacturers, their suppliers, and the people behind the scenes who are responsible for cutting-edge products that save lives, improve patient care, and transform medtech—one innovation at a time.
From Gary Warren, President & CEO of ivWatch
“It’s an honor to be named as one of the finalists,” says Gary Warren, ivWatch President & CEO. “Having our device recognized by the MDEA judges validates our commitment to helping reduce patient harm and improving patient safety outcomes.”
Suppliers who contributed to the development and production of the Model 400 are Insight Product Development, Phillips-Medisize Corp, Gulf Fiberoptics/Gulf Photonics, and Minnetronix.
Contact: Leah Moore, Director, Marketing
855-489-2824 ext. 7031
Source: ivWatch, LLC